NSE level in combined neuroendocrine and adenocarcinoma EGFR mutated lung cancer resistant to EGFR-TKI

被引：6
|
作者：
Facchinetti, Francesco [1 ]
Tiseo, Marcello [1 ]
Gnetti, Letizia [2 ]
Silini, Enrico Maria [2 ]
Ardizzoni, Andrea [1 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, I-43100 Parma, Italy
[2] Univ Hosp Parma, Surg Pathol Unit, I-43100 Parma, Italy
来源：
LUNG CANCER | 2013年 / 82卷 / 01期
关键词：
CARCINOMA;
D O I：
10.1016/j.lungcan.2013.07.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：177 / 178
页数：2
相关论文
共 39 条
  • [21] Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer
    Iijima, Yuki
    Hirotsu, Yosuke
    Mochizuki, Hitoshi
    Ikmemiya, Kenji
    Oyama, Toshio
    Uchida, Yoshinori
    Kobayashi, Yoichi
    Tsutsui, Toshiharu
    Kakizaki, Yumiko
    Miyashita, Yoshihiro
    Omata, Masao
    CLINICAL LUNG CANCER, 2018, 19 (06) : E843 - E847
  • [22] Early Application of Next-Generation Sequencing Identifies Pancreatic Mass as Metastasis From an EGFR-Mutated Lung Adenocarcinoma
    Chen, Luxi
    Davelaar, John
    Gaddam, Srinivas
    Kosari, Kambiz
    Nissen, Nicholas
    Chaux, George
    Lee, Christopher
    Vail, Eric
    Hendifar, Andrew
    Gong, Jun
    Reckamp, Karen
    Osipov, Arsen
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 6 - 11
  • [23] Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis
    Deng, Guangchuan
    Tan, Xiaojing
    Li, Yankang
    Zhang, Yingyun
    Wang, Qi
    Li, Jianbin
    Li, Zhenxiang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] Traditional Chinese Medicine Proton vs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations
    Tang, Mo
    Wang, Shumei
    Zhao, Bin
    Wang, Wei
    Zhu, Yuxi
    Hu, Lingjing
    Zhang, Xianquan
    Xiong, Shaoquan
    MEDICAL SCIENCE MONITOR, 2019, 25 : 8430 - 8437
  • [25] Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI
    Yi, Hyeon Gyu
    Kim, Hye Jin
    Kim, Yu Jung
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Kim, Tae-You
    Kim, Chul Soo
    Heo, Dae Seog
    Bang, Yung-Jue
    LUNG CANCER, 2009, 65 (01) : 80 - 84
  • [26] Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer
    Marrett, Elizabeth
    Kwong, Winghan Jacqueline
    Chow, Laura Q. M.
    FUTURE ONCOLOGY, 2022, 18 (13) : 1535 - 1544
  • [27] EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
    Soria, Jean-Charles
    Mok, Tony S.
    Cappuzzo, Federico
    Jaenne, Pasi A.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 416 - 430
  • [28] B7-H4 and HHLA2, members of B7 family, are aberrantly expressed in EGFR mutated lung adenocarcinoma
    Chen, Yan
    Hu, Ran
    Li, Xiaoyou
    Shi, Zhongyuan
    Tian, Hao
    Feng, Jifeng
    Yu, Shaorong
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (10)
  • [29] Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma
    Ali, Greta
    Bruno, Rossella
    Giordano, Mirella
    Prediletto, Irene
    Marconi, Letizia
    Zupo, Simonetta
    Fedeli, Franco
    Ribechini, Alessandro
    Chella, Antonio
    Fontanini, Gabriella
    ONCOLOGY LETTERS, 2016, 12 (05) : 4009 - 4012
  • [30] Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder
    Bersanelli, Melissa
    Bini, Paola
    Rabaiotti, Enrico
    Facchinetti, Francesco
    De Filippo, Massimo
    Bortesi, Beatrice
    Buti, Sebastiano
    Tiseo, Marcello
    TUMORI, 2017, 103 (01) : 66 - 71
1234